These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11471302)

  • 21. Novel immunosuppression: small molecules and biologics.
    Yabu JM; Vincenti F
    Semin Nephrol; 2007 Jul; 27(4):479-86. PubMed ID: 17616278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can the early elimination of calcineurin inhibitors result in clinical benefits?
    Weir MR
    Transplant Proc; 2010 Nov; 42(9 Suppl):S16-20. PubMed ID: 21095444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New perspectives in immunosuppression].
    Sádaba B; Azanza JR; Muñoz MJ; Gil I
    Nefrologia; 2005; 25(5):475-84, 486-8, 490-2. PubMed ID: 16392297
    [No Abstract]   [Full Text] [Related]  

  • 24. High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation.
    Gelens MA; Christiaans MH; van Heurn EL; van den Berg-Loonen EP; Peutz-Kootstra CJ; van Hooff JP
    Transplantation; 2006 Nov; 82(9):1221-3. PubMed ID: 17102775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational clinical regimens for kidney transplant immunosuppression.
    Belitsky P
    Transplant Proc; 1994 Oct; 26(5):2485-9. PubMed ID: 7940763
    [No Abstract]   [Full Text] [Related]  

  • 26. WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation.
    Dresske B; Zavazava N; Jenisch S; Exner B; Lenz P; El Mokhtari NE; Kremer B; Faendrich F
    Transplantation; 2003 Apr; 75(8):1286-91. PubMed ID: 12717217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New immunosuppressive therapies in kidney transplantation].
    Pomer S
    Urologe A; 1994 Sep; 33(5):370-6. PubMed ID: 7974924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression in small bowel transplantation--treatment with a monoclonal IL-2 receptor antibody (NDS 61).
    Schweizer E; Papachrysanthou A; Faendrich F; Deltz E; Schroeder P
    Transplant Proc; 1994 Dec; 26(6):3142-3. PubMed ID: 7998095
    [No Abstract]   [Full Text] [Related]  

  • 29. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection.
    Kreis H; Chkoff N; Chatenoud L; Debure A; Lacombe M; Chrétien Y; Legendre C; Caillat S; Bach JF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1741-4. PubMed ID: 2652570
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunosuppression and treatment of graft rejection after kidney transplantation].
    May G
    Urologe A; 1994 Sep; 33(5):365-9. PubMed ID: 7974923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: state of the art and future developments.
    Giessing M; Fuller TF; Tuellmann M; Slowinski T; Budde K; Liefeldt L
    World J Urol; 2007 Jun; 25(3):325-32. PubMed ID: 17333201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic calcineurin inhibitor use is nephrotoxic.
    Chapman JR
    Clin Pharmacol Ther; 2011 Aug; 90(2):207-9. PubMed ID: 21772296
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody].
    Campana C
    Ital Heart J Suppl; 2000 Jun; 1(6):838-9. PubMed ID: 11204021
    [No Abstract]   [Full Text] [Related]  

  • 36. Current trends in immunosuppression.
    González Posada JM
    Nefrologia; 2006; 26 Suppl 2():3-8. PubMed ID: 17937629
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical immunosuppressive matrix in organ transplantation.
    Land W
    Transplant Proc; 1994 Oct; 26(5):2479-84. PubMed ID: 7940762
    [No Abstract]   [Full Text] [Related]  

  • 38. New developments in clinical immunosuppression.
    Watschinger B; Wenter C; Demetriou D
    Kidney Blood Press Res; 2000; 23(3-5):191-2. PubMed ID: 11031719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical immunosuppressive regimens and clinical results in renal transplantation.
    Bertolatus JA
    Semin Nephrol; 1992 Jul; 12(4):332-42. PubMed ID: 1410861
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of immunosuppressive drugs in kidney transplantation.
    Salomon DR
    Pharmacotherapy; 1991; 11(6):153S-164S. PubMed ID: 1771141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.